We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
69 hedge funds and large institutions have $334M invested in Revance Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 14 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
129% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 14
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
11% more capital invested
Capital invested by funds: $301M → $334M (+$32.8M)
14% less funds holding
Funds holding: 80 → 69 (-11)
48% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $46K
Holders
69
Holders Change
-11
Holders Change %
-13.75%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
12
Increased
32
Reduced
14
Closed
23
Calls
–
Puts
$46K
Net Calls
-$46K
Net Calls Change
-$46K
Top Buyers
| 1 |
Franklin Resources
San Mateo,
California
|
+$23.9M |
| 2 |
VAM
Visium Asset Management
New York
|
+$17.5M |
| 3 |
Bank of New York Mellon
New York
|
+$16.4M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$7.29M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.48M |
